Molecular neuroimaging in primary progressive aphasia with predominant agraphia

Research output: Contribution to journalArticle

Abstract

A 62-year-old male presented with progressive isolated writing and spelling difficulties. Neurological, neuropsychological, speech, and language evaluations identified only minimal additional abnormalities. The presenting characteristics did not meet criteria for any particular variant of primary progressive aphasia; his clinical presentation is best described as primary progressive aphasia, with a predominant, almost pure agraphia. Brain MRI showed asymmetric, bilateral parenchymal volume loss, with left hippocampal atrophy. Fluorodeoxyglucose-F18 positron emission tomography showed hypometabolism in the lateral left frontal lobe, including Exner’s area. Beta-amyloid and tau-positron emission tomography scans were negative, indicating the etiology was not Alzheimer’s disease. The underlying neurodegenerative process is most likely related to TDP-43, although a 4-repeat tauopathy cannot be excluded. Following his clinical evolution, and ultimately identifying the underlying pathology from autopsy, will elucidate the etiology of this interesting clinical presentation.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalNeurocase
DOIs
StateAccepted/In press - Mar 25 2018

Fingerprint

Primary Progressive Aphasia
Agraphia
Neuroimaging
Positron-Emission Tomography
Tauopathies
Fluorodeoxyglucose F18
Frontal Lobe
Amyloid
Atrophy
Autopsy
Alzheimer Disease
Language
Pathology
Brain
Positron Emission Tomography
Etiology

Keywords

  • agraphia
  • frontotemporal dementia
  • MRI
  • PET
  • Primary progressive aphasia

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

@article{3ab6c4d8d4ba4160b37f56d013e00754,
title = "Molecular neuroimaging in primary progressive aphasia with predominant agraphia",
abstract = "A 62-year-old male presented with progressive isolated writing and spelling difficulties. Neurological, neuropsychological, speech, and language evaluations identified only minimal additional abnormalities. The presenting characteristics did not meet criteria for any particular variant of primary progressive aphasia; his clinical presentation is best described as primary progressive aphasia, with a predominant, almost pure agraphia. Brain MRI showed asymmetric, bilateral parenchymal volume loss, with left hippocampal atrophy. Fluorodeoxyglucose-F18 positron emission tomography showed hypometabolism in the lateral left frontal lobe, including Exner’s area. Beta-amyloid and tau-positron emission tomography scans were negative, indicating the etiology was not Alzheimer’s disease. The underlying neurodegenerative process is most likely related to TDP-43, although a 4-repeat tauopathy cannot be excluded. Following his clinical evolution, and ultimately identifying the underlying pathology from autopsy, will elucidate the etiology of this interesting clinical presentation.",
keywords = "agraphia, frontotemporal dementia, MRI, PET, Primary progressive aphasia",
author = "Rene Utianski and Duffy, {Joseph R.} and Rodolfo Savica and Whitwell, {Jennifer Lynn} and Machulda, {Mary Margaret} and Josephs, {Keith Anthony}",
year = "2018",
month = "3",
day = "25",
doi = "10.1080/13554794.2018.1454963",
language = "English (US)",
pages = "1--3",
journal = "Neurocase",
issn = "1355-4794",
publisher = "Psychology Press Ltd",

}

TY - JOUR

T1 - Molecular neuroimaging in primary progressive aphasia with predominant agraphia

AU - Utianski, Rene

AU - Duffy, Joseph R.

AU - Savica, Rodolfo

AU - Whitwell, Jennifer Lynn

AU - Machulda, Mary Margaret

AU - Josephs, Keith Anthony

PY - 2018/3/25

Y1 - 2018/3/25

N2 - A 62-year-old male presented with progressive isolated writing and spelling difficulties. Neurological, neuropsychological, speech, and language evaluations identified only minimal additional abnormalities. The presenting characteristics did not meet criteria for any particular variant of primary progressive aphasia; his clinical presentation is best described as primary progressive aphasia, with a predominant, almost pure agraphia. Brain MRI showed asymmetric, bilateral parenchymal volume loss, with left hippocampal atrophy. Fluorodeoxyglucose-F18 positron emission tomography showed hypometabolism in the lateral left frontal lobe, including Exner’s area. Beta-amyloid and tau-positron emission tomography scans were negative, indicating the etiology was not Alzheimer’s disease. The underlying neurodegenerative process is most likely related to TDP-43, although a 4-repeat tauopathy cannot be excluded. Following his clinical evolution, and ultimately identifying the underlying pathology from autopsy, will elucidate the etiology of this interesting clinical presentation.

AB - A 62-year-old male presented with progressive isolated writing and spelling difficulties. Neurological, neuropsychological, speech, and language evaluations identified only minimal additional abnormalities. The presenting characteristics did not meet criteria for any particular variant of primary progressive aphasia; his clinical presentation is best described as primary progressive aphasia, with a predominant, almost pure agraphia. Brain MRI showed asymmetric, bilateral parenchymal volume loss, with left hippocampal atrophy. Fluorodeoxyglucose-F18 positron emission tomography showed hypometabolism in the lateral left frontal lobe, including Exner’s area. Beta-amyloid and tau-positron emission tomography scans were negative, indicating the etiology was not Alzheimer’s disease. The underlying neurodegenerative process is most likely related to TDP-43, although a 4-repeat tauopathy cannot be excluded. Following his clinical evolution, and ultimately identifying the underlying pathology from autopsy, will elucidate the etiology of this interesting clinical presentation.

KW - agraphia

KW - frontotemporal dementia

KW - MRI

KW - PET

KW - Primary progressive aphasia

UR - http://www.scopus.com/inward/record.url?scp=85044372185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044372185&partnerID=8YFLogxK

U2 - 10.1080/13554794.2018.1454963

DO - 10.1080/13554794.2018.1454963

M3 - Article

C2 - 29569990

AN - SCOPUS:85044372185

SP - 1

EP - 3

JO - Neurocase

JF - Neurocase

SN - 1355-4794

ER -